References
- 1. B. Healy and R. Barnes, Topical and oral treatments for fungal skin infections, Prescriber 17(7) (2006) 30–43; https://doi.org/10.1002/psb.360
- 2. R. Coppola, S. Zanframundo, M. V. Rinati, M. Carbotti, A. Graziano, G. Galati, L. De Florio and V. Panasiti, Rhodotorula mucilaginosa skin infection in a patient treated with sorafenib, J. Eur. Acad. Dermatol. Venereol. 29(5) (2015) 1028–1029; https://doi.org/10.1111/jdv.12455
- 3. E. Palese, M. Nudo, G. Zino, V. Devirgiliis, M. Carbotti, E. Cinelli, D. M. Rodio, A. Bressan, C. Prezioso, C. Ambrosi, D. Scribano, V. Pietropaolo, D. Fioriti and V. Panasiti, Cutaneous candidiasis caused by Candida albicans in a young non-immunosuppressed patient: an unusual presentation, Int. J. Immunopathol. Pharmacol. 32 (2018) 1–4; https://doi.org/10.1177/2058738418781368
- 4. S. Bhattacharya, S. Sae-Tia and B. C. Fries, Candidiasis and mechanisms of antifungal resistance, Antibiotics 9(6) (2020) Article ID 312 (19 pages); https://doi.org/10.3390/antibiotics9060312
- 5. M. V. Martin, The use of fluconazole and itraconazole in the treatment of Candida albicans infections: a review, J. Antimicrob. Chemother. 44(4) (1999) 429–437; https://doi.org/10.1093/jac/44.4.429
- 6. P. Suchil, F. Montero Gei, M. Robles, A. Perera-Ramirez, O. Welsh and O. Male, Once-weekly oral doses of fluconazole 150 mg in the treatment of tinea corporis/cruris and cutaneous candidiasis, Clin. Exp. Dermatol. 17(6) (1992) 397–401; https://doi.org/10.1111/j.1365-2230.1992.tb00246.x
- 7. B. Darwesh, H. M. Aldawsari and S. M. Badr-Eldin, Optimized chitosan/anion polyelectrolyte complex based inserts for vaginal delivery of fluconazole: In vitro/in vivo evaluation, Pharmaceutics 10(4) (2018) Article ID 227 (16 pages); https://doi.org/10.3390/pharmaceutics10040227
- 8. H. M. Ellaithy and K. M. F. El-Shaboury, The development of Cutina lipogels and gel microemulsion for topical administration of fluconazole, AAPS PharmSciTech 3 (2002) 77–85; https://doi.org/10.1208/pt030435
- 9. M. Gupta, S. Tiwari and S. P. Vyas, Influence of various lipid core on characteristics of SLNs designed for topical delivery of fluconazole against cutaneous candidiasis, Pharm. Dev. Technol. 18(3) (2013) 550–559; https://doi.org/10.3109/10837450.2011.598161
- 10. V. Prajapati, A. Jain, R. Jain, S. Sahu and D. V. Kohli, Treatment of cutaneous candidiasis through fluconazole encapsulated cubosomes, Drug Deliv. Transl. Res. 4 (2014) 400–408; https://doi.org/10.1007/s13346-014-0202-2
- 11. T. O. McDonald, M. Siccardi, D. Moss, N. Liptrott, M. Giardiello, S. Rannard and A. Owen, The Application of Nanotechnology to Drug Delivery in Medicine, in Nanoengineering Global Approaches to Health and Safety Issues, Elsevier 2015, pp. 173–223.
- 12. W. Weng, Q. Wang, C. Wei, M. Adu-Frimpong, E. Toreniyazov, H. Ji, J. Yu and X. Xu, Mixed micelles for enhanced oral bioavailability and hypolipidemic effect of liquiritin: preparation, in vitro and in vivo evaluation, Drug Dev. Ind. Pharm. 47(2) (2021) 308–318; https://doi.org/10.1080/03639045.2021.1879839
- 13. O. A. A. Ahmed, K. M. El-Say, B. M. Aljaeid, S. M. Badr-Eldin and T. A. Ahmed, Optimized vinpocetine-loaded vitamin E D-α-tocopherol polyethylene glycol 1000 succinate-alpha lipoic acid micelles as a potential transdermal drug delivery system: in vitro and ex vivo studies, Int. J. Nanomedicine 2018(14) 33–43; https://doi.org/10.2147/IJN.S187470
- 14. O. A. A. Ahmed and S. M. Badr-Eldin, In situ misemgel as a multifunctional dual-absorption platform for nasal delivery of raloxifene hydrochloride: formulation, characterization, and in vivo performance, Int. J. Nanomedicine 2018(13) 6325–6335; https://doi.org/10.2147/IJN.S181587
- 15. J. Sobczyński and B. Chudzik-Rząd, Mixed Micelles as Drug Delivery Nanocarriers, in Design and Develop ment of New Nanocarriers, Elsevier 2018, pp. 331–364.
- 16. L. C. Chen, Y. C. Chen, C. Y. Su, W. P. Wong, M. T. Sheu and H. O. Ho, Development and Characterization of lecithin-based self-assembling mixed polymeric micellar (saMPMs) drug delivery systems for curcumin, Sci. Rep. 6 (2016) Article ID 37122 (11 pages); https://doi.org/10.1038/srep37122
- 17. L. Mu and S. S. Feng, PLGA/TPGS nanoparticles for controlled release of paclitaxel: effects of the emulsifier and drug loading ratio, Pharm. Res. 20 (2003) 1864–1872; https://doi.org/10.1023/B:PHAM.0000003387.15428.42
- 18. J. Song, H. Huang, Z. Xia, Y. Wei, N. Yao, L. Zhang, H. Yan, X. Jia and Z. Zhang, TPGS/phospholipids mixed micelles for delivery of icariside II to multidrug-resistant breast cancer, Integr. Cancer Ther. 15(3) (2016) 390–399; https://doi.org/10.1177/1534735415596571
- 19. M. L. Manca, C. Cencetti, P. Matricardi, I. Castangia, M. Zaru, O. D. Sales, A. Nacher, D. Valenti, A. M. Maccioni, A. M. Fadda and M. Manconi, Glycerosomes: Use of hydrogenated soy phosphatidylcholine mixture and its effect on vesicle features and diclofenac skin penetration, Int. J. Pharm. 511(1) (2016) 198–204; https://doi.org/10.1016/j.ijpharm.2016.07.009
- 20. M. J. Naguib, S. Salah, S. A. Abdel Halim and S. M. Badr-Eldin, Investigating the potential of utilizing glycerosomes as a novel vesicular platform for enhancing intranasal delivery of lacidipine, Int. J. Pharm. 582 (2020) Article ID 119302 (14 pages); https://doi.org/10.1016/j.ijpharm.2020.119302
- 21. R. Shen, J. Kim, M. Yao and T. A. Elbayoumi, Development and evaluation of vitamin E D-α-tocopheryl polyethylene glycol 1000 succinate-mixed polymeric phospholipid micelles of berberine as an anticancer nanopharmaceutical, Int. J. Nanomedicine 2016(11) 1687–1700; https://doi.org/10.2147/IJN.S103332
- 22. N. A. Alhakamy, O. A. Ahmed, U. A. Fahmy, H. Z. Asfour, A. F. Alghaith, W. A. Mahdi, S. Alshehri and S. Md, Development, Optimization and evaluation of 2-methoxy-estradiol loaded nanocarrier for prostate cancer, Front. Pharmacol. 12 (2021) Article ID 682337 (14 pages); https://doi.org/10.3389/FPHAR.2021.682337
- 23. W. H. Abd-Elsalam, S. A. El-Zahaby and A. M. Al-Mahallawi, Formulation and in vivo assessment of terconazole-loaded polymeric mixed micelles enriched with Cremophor EL as dual functioning mediator for augmenting physical stability and skin delivery, Drug Deliv. 25(1) (2018) 484–492; https://doi.org/10.1080/10717544.2018.1436098
- 24. P. Sadasivudu, N. Shastri and M. Sadanandam, Development and validation of RP-HPLC and UV methods of analysis for fluconazole in pharmaceutical solid dosage forms, Int. J. ChemTech Res. 1(4) (2009) 1131–1136.
- 25. S. El-Housiny, M. A. S. Eldeen, Y. A. El-Attar, H. A. Salem, D. Attia, E. R. Bendas and M. A. El-Nabarawi, Fluconazole-loaded solid lipid nanoparticles topical gel for treatment of pityriasis versicolor: formulation and clinical study, Drug Deliv. 25(1) (2018) 78–90; https://doi.org/10.1080/10717544.2017.1413444
- 26. I. Angulo, M. B. Jiménez-Díaz, J. F. García-Bustos, D. Gargallo, F. Gómez de las Heras, M. A. Muñoz-Fernández and M. Fresno, Candida albicans infection enhances immunosuppression induced by cyclophosphamide by selective priming of suppressive myeloid progenitors for NO production, Cell. Immunol. 218(1–2) (2002) 46–58; https://doi.org/10.1016/S0008-8749(02)00521-X
- 27. K. Maebashi, T. Itoyama, K. Uchida, N. Suegara and H. Yamaguchi, A novel model of cutaneous candidiasis produced in prednisolone-treated guinea-pigs, J. Med. Vet. Mycol. 32(5) (1994) 349–359; https://doi.org/10.1080/02681219480000471
- 28. S. M. Badr-Eldin, N. A. Alhakamy, U. A. Fahmy, O. A. A. Ahmed, H. Z. Asfour, A. A. Althagafi, H. M. Aldawsari, W. Y. Rizg, W. A. Mahdi, A. F. Alghaith, S. Alshehri, F. Caraci and G. Caruso, Cytotoxic and pro-apoptotic effects of a sub-toxic concentration of fluvastatin on OVCAR3 ovarian cancer cells after its optimized formulation to melittin nano-conjugates, Front. Pharmacol. 11 (2021) Article ID 642171 (12 pages); https://doi.org/10.3389/fphar.2020.642171
- 29. U. A. Fahmy, S. M. Badr-Eldin, O. A. A. Ahmed, H. M. Aldawsari, S. Tima, H. Z. Asfour, M. W. Al-Rabia, A. A. Negm, M. H. Sultan, O. A. A. Madkhali and N. A. Alhakamy, Intranasal niosomal in situ gel as a promising approach for enhancing flibanserin bioavailability and brain delivery: In vitro optimization and ex vivo/in vivo evaluation, Pharmaceutics 12(6) (2020) Article ID 485 (23 pages); https://doi.org/10.3390/pharmaceutics12060485
- 30. Z. M. Adib, S. Ghanbarzadeh, M. Kouhsoltani, A. Y. Khosroshahi and H. Hamishehkar, The effect of particle size on the deposition of solid lipid nanoparticles in different skin layers: A histological study, Adv. Pharm. Bull. 6(1) (2016) 31–36; https://doi.org/10.15171/apb.2016.006
- 31. R. Sharma, S. Kamboj, G. Singh and V. Rana, Development of aprepitant loaded orally disintegrating films for enhanced pharmacokinetic performance, Eur. J. Pharm. Sci. 84 (2016) 55–69; https://doi.org/10.1016/j.ejps.2016.01.006
- 32. J. Singh, P. Mittal, G. Vasant Bonde, G. Ajmal and B. Mishra, Design, optimization, characterization and in-vivo evaluation of Quercetin enveloped Soluplus®/P407 micelles in diabetes treatment, Artif. Cells Nanomedicine Biotechnol. 46(sup3) (2018) S546–S555; https://doi.org/10.1080/21691401.2018.1501379
- 33. A. E. S. F. Abou El Ela and M. M. El Khatib, Formulation and evaluation of new long acting metoprolol tartrate ophthalmic gels, Saudi Pharm. J. 22(6) (2014) 555–563; https://doi.org/10.1016/j.jsps.2014.03.003
- 34. A. A. Alhowyan, M. A. Altamimi, M. A. Kalam, A. A. Khan, M. Badran, Z. Binkhathlan, M. Alkholief and A. Alshamsan, Antifungal efficacy of Itraconazole loaded PLGA-nanoparticles stabilized by vitamin-E TPGS: In vitro and ex vivo studies, J. Microbiol. Methods 161 (2019) 87–95; https://doi.org/10.1016/j.mimet.2019.01.020
- 35. L. Qiu, B. Hu, H. Chen, S. Li, Y. Hu, Y. Zheng and X. Wu, Antifungal efficacy of itraconazole-loaded TPGS-b-(PCL-ran-PGA) nanoparticles, Int. J. Nanomedicine 2015(10) 1415–1423; https://doi.org/10.2147/IJN.S71616